Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosaria Maria Pipitone

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2020
Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosisFederico Salomone, Salvatore Petta, Agnieszka Micek, et al.
European Journal of Medicinal Chemistry|July 12, 2011
3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: a novel class of potent tubulin inhibitorsAntonio Carta, Irene Briguglio, Sandra Piras, et al.
Hepatology Communications|February 11, 2022
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver DiseaseGrazia Pennisi, Rosaria Maria Pipitone, Marco Enea, et al.
Plos One|September 27, 2013
PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver diseaseSalvatore Petta, Luca Valenti, Giulio Marchesini, et al.
Journal of Hepatology|November 25, 2015
MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver diseaseSalvatore Petta, Luca Valenti, Fabio Marra, et al.
Cardiovascular Diabetology|June 26, 2023
Metabolic memory in diabetic foot syndrome (DFS): MICRO-RNAS, single nucleotide polymorphisms (SNPs) frequency and their relationship with indices of endothelial function and adipo-inflammatory dysfunctionAlessandro Del Cuore, Rosaria Maria Pipitone, Alessandra Casuccio, et al.
The Journal of Clinical Endocrinology and Metabolism|May 5, 2017
Fibronectin Type III Domain-Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseSalvatore Petta, Luca Valenti, Gianluca Svegliati-Baroni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2021
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver diseaseStefania Grimaudo, Paola Dongiovanni, Jussi Pihlajamäki, et al.
Gastroenterology|December 21, 2020
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver DiseaseOveis Jamialahmadi, Rosellina Margherita Mancina, Ester Ciociola, et al.
Journal of Hepatology|March 6, 2018
Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosisSalvatore Petta, Luigi Elio Adinolfi, Anna Ludovica Fracanzani, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2020
Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosisFederico Salomone, Salvatore Petta, Agnieszka Micek, et al.
European Journal of Medicinal Chemistry|July 12, 2011
3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: a novel class of potent tubulin inhibitorsAntonio Carta, Irene Briguglio, Sandra Piras, et al.
Hepatology Communications|February 11, 2022
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver DiseaseGrazia Pennisi, Rosaria Maria Pipitone, Marco Enea, et al.
Plos One|September 27, 2013
PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver diseaseSalvatore Petta, Luca Valenti, Giulio Marchesini, et al.
Journal of Hepatology|November 25, 2015
MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver diseaseSalvatore Petta, Luca Valenti, Fabio Marra, et al.
Cardiovascular Diabetology|June 26, 2023
Metabolic memory in diabetic foot syndrome (DFS): MICRO-RNAS, single nucleotide polymorphisms (SNPs) frequency and their relationship with indices of endothelial function and adipo-inflammatory dysfunctionAlessandro Del Cuore, Rosaria Maria Pipitone, Alessandra Casuccio, et al.
The Journal of Clinical Endocrinology and Metabolism|May 5, 2017
Fibronectin Type III Domain-Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseSalvatore Petta, Luca Valenti, Gianluca Svegliati-Baroni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2021
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver diseaseStefania Grimaudo, Paola Dongiovanni, Jussi Pihlajamäki, et al.
Gastroenterology|December 21, 2020
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver DiseaseOveis Jamialahmadi, Rosellina Margherita Mancina, Ester Ciociola, et al.
Journal of Hepatology|March 6, 2018
Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosisSalvatore Petta, Luigi Elio Adinolfi, Anna Ludovica Fracanzani, et al.
Pageof 5